DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,395 filers reported holding DANAHER CORPORATION in Q2 2019. The put-call ratio across all filers is 0.58 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,577,000 | +9.1% | 18,030 | +0.7% | 0.29% | +9.8% |
| Q1 2019 | $2,362,000 | +27.8% | 17,896 | -0.2% | 0.27% | +16.2% |
| Q4 2018 | $1,848,000 | -5.3% | 17,927 | -0.2% | 0.23% | +13.4% |
| Q3 2018 | $1,951,000 | +10.1% | 17,957 | 0.0% | 0.20% | +5.8% |
| Q2 2018 | $1,772,000 | -0.8% | 17,957 | -1.6% | 0.19% | -2.1% |
| Q1 2018 | $1,786,000 | +5.6% | 18,247 | +0.1% | 0.20% | +7.1% |
| Q4 2017 | $1,692,000 | +6.8% | 18,233 | -1.3% | 0.18% | +3.4% |
| Q3 2017 | $1,585,000 | +1.0% | 18,477 | -0.6% | 0.18% | +2.9% |
| Q2 2017 | $1,569,000 | 0.0% | 18,592 | +1.3% | 0.17% | -1.7% |
| Q1 2017 | $1,569,000 | +9.8% | 18,347 | 0.0% | 0.17% | +6.1% |
| Q4 2016 | $1,429,000 | +6.1% | 18,347 | +6.8% | 0.16% | -9.9% |
| Q3 2016 | $1,347,000 | -22.3% | 17,175 | +0.1% | 0.18% | -24.2% |
| Q2 2016 | $1,733,000 | +6.3% | 17,152 | -0.2% | 0.24% | +4.8% |
| Q1 2016 | $1,631,000 | -9.7% | 17,192 | -11.6% | 0.23% | -9.1% |
| Q4 2015 | $1,806,000 | +6.0% | 19,449 | -2.7% | 0.25% | +2.9% |
| Q3 2015 | $1,703,000 | -0.5% | 19,984 | -0.1% | 0.24% | +7.9% |
| Q2 2015 | $1,712,000 | -2.7% | 20,009 | -3.5% | 0.23% | -1.3% |
| Q1 2015 | $1,760,000 | -1.8% | 20,741 | -0.8% | 0.23% | -1.3% |
| Q4 2014 | $1,792,000 | +14.4% | 20,907 | +1.5% | 0.23% | -14.3% |
| Q3 2014 | $1,566,000 | -4.7% | 20,607 | -1.3% | 0.27% | -2.5% |
| Q2 2014 | $1,644,000 | +2.9% | 20,877 | -1.9% | 0.28% | -2.8% |
| Q1 2014 | $1,597,000 | -5.3% | 21,283 | -2.6% | 0.29% | -4.3% |
| Q4 2013 | $1,687,000 | +11.6% | 21,853 | +0.2% | 0.30% | +2.4% |
| Q3 2013 | $1,511,000 | +6.1% | 21,803 | -3.0% | 0.29% | +4.3% |
| Q2 2013 | $1,424,000 | – | 22,486 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |